|
|
供应 LDK378 /1032900-25-6 |
规 格: |
克 |
价 格: |
1/ |
数 量: |
999 |
交货地: |
全国 |
发布时间: |
2015-11-03 |
有效期: |
255天 |
备 注: |
CAS NO. 1032900-25-6
英文品名 LDK378
中文品名 色瑞替尼
分子式 C28H36ClN5O3S
分子量 558.14
规格/纯度 98%
供应能力 can supply large quantity in kgs scale
别名 LDK 378; LDK-378; Ceritinib
产品简述 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) .
详细说明 LDK378 is a highly selective inhibitor of an important cancer target, anaplastic lymphoma kinase (ALK) . LDK378 has received Breakthrough Therapy designation by the US Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during treatment with, or were intolerant to, crizotinib. Approximately 3-8% of patients with NSCLC have the ALK gene mutation [1]. There are limited tr
|
结构式: |
|
|
|